310 related articles for article (PubMed ID: 17162851)
21. Double visualization using triamcinolone acetonide and trypan blue during stage 3 macular hole surgery.
Yamamoto N; Ozaki N; Murakami K
Ophthalmologica; 2004; 218(5):297-305. PubMed ID: 15334009
[TBL] [Abstract][Full Text] [Related]
22. Anatomic and functional outcome after 23-gauge vitrectomy, peeling, and intravitreal triamcinolone for idiopathic macular epiretinal membrane.
Konstantinidis L; Berguiga M; Beknazar E; Wolfensberger TJ
Retina; 2009 Sep; 29(8):1119-27. PubMed ID: 19734764
[TBL] [Abstract][Full Text] [Related]
23. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.
Jahn CE; Töpfner von Schutz K; Richter J; Boller J; Kron M
Ophthalmologica; 2004; 218(6):378-84. PubMed ID: 15564755
[TBL] [Abstract][Full Text] [Related]
24. Reduced incidence of intraoperative complications in a multicenter controlled clinical trial of triamcinolone in vitrectomy.
Yamakiri K; Sakamoto T; Noda Y; Nakahara M; Ogino N; Kubota T; Yokoyama M; Furukawa M; Sonoda Y; Yamada T; Doi N; Enaida H; Hata Y; Ishibashi T
Ophthalmology; 2007 Feb; 114(2):289-96. PubMed ID: 17270679
[TBL] [Abstract][Full Text] [Related]
25. Intravitreal triamcinolone reduces the morphologic changes of ciliary body after pars plana vitrectomy for retinal vascular diseases.
Lee GH; Ahn JK; Park YG
Am J Ophthalmol; 2008 Jun; 145(6):1037-1044. PubMed ID: 18378211
[TBL] [Abstract][Full Text] [Related]
26. Intravitreal triamcinolone acetonide as an additional tool in pars plana vitrectomy for proliferative diabetic retinopathy.
Jonas JB; Söfker A; Degenring R
Eur J Ophthalmol; 2003 Jun; 13(5):468-73. PubMed ID: 12841570
[TBL] [Abstract][Full Text] [Related]
27. Pars plana vitrectomy assisted by triamcinolone acetonide for refractory uveitis: a case series study.
Sonoda KH; Enaida H; Ueno A; Nakamura T; Kawano YI; Kubota T; Sakamoto T; Ishibashi T
Br J Ophthalmol; 2003 Aug; 87(8):1010-4. PubMed ID: 12881346
[TBL] [Abstract][Full Text] [Related]
28. Long-term outcomes of administration of intravitreal triamcinolone acetonide after posterior vitreous detachment during pars plana vitrectomy for proliferative diabetic retinopathy.
Liao M; Huang Y; Wang J; Meng X; Liu Y; Yu J; Yan H
Br J Ophthalmol; 2023 Apr; 107(4):560-564. PubMed ID: 34844917
[TBL] [Abstract][Full Text] [Related]
29. Long-term clinical outcomes and therapeutic benefits of triamcinolone-assisted pars plana vitrectomy for proliferative vitreoretinopathy: a case study.
Ueno A; Enaida H; Hata Y; Hisatomi T; Nakamura T; Mochizuki Y; Sakamoto T; Ishibashi T
Eur J Ophthalmol; 2007; 17(3):392-8. PubMed ID: 17534822
[TBL] [Abstract][Full Text] [Related]
30. Anatomical and visual outcome after vitrectomy with triamcinolone acedonide-assisted epiretinal membrane removal in highly myopic eyes with retinal detachment due to macular hole.
Fang X; Zheng X; Weng Y; Chen Z; Liu J; Chen B; Wu P; Ni H; Yao K
Eye (Lond); 2009 Feb; 23(2):248-54. PubMed ID: 18344953
[TBL] [Abstract][Full Text] [Related]
31. Vitrectomy for diabetic macular edema: the role of posterior vitreous detachment and epimacular membrane.
Yamamoto T; Akabane N; Takeuchi S
Am J Ophthalmol; 2001 Sep; 132(3):369-77. PubMed ID: 11530050
[TBL] [Abstract][Full Text] [Related]
32. Pars plana vitrectomy with removal of posterior hyaloid face in treatment of refractory diabetic macular edema resistant to triamcinolone acetonide.
Higuchi A; Ogata N; Jo N; Wada M; Matsumura M
Jpn J Ophthalmol; 2006; 50(6):529-531. PubMed ID: 17180527
[TBL] [Abstract][Full Text] [Related]
33. Comparison of ICG-assisted ILM peeling and triamcinolone-assisted posterior vitreous removal in diffuse diabetic macular oedema.
Bardak Y; Cekiç O; Tiğ SU
Eye (Lond); 2006 Dec; 20(12):1357-9. PubMed ID: 16294204
[TBL] [Abstract][Full Text] [Related]
34. Pars plana lensectomy, pars plana vitrectomy, and silicone oil tamponade as initial management of cataract and combined traction/rhegmatogenous retinal detachment involving the macula associated with severe proliferative diabetic retinopathy.
Douglas MJ; Scott IU; Flynn HW
Ophthalmic Surg Lasers Imaging; 2003; 34(4):270-8. PubMed ID: 12875454
[TBL] [Abstract][Full Text] [Related]
35. Visualizing vitreous in vitrectomy by triamcinolone.
Sakamoto T; Ishibashi T
Graefes Arch Clin Exp Ophthalmol; 2009 Sep; 247(9):1153-63. PubMed ID: 19543906
[TBL] [Abstract][Full Text] [Related]
36. Trans-Tenon's retrobulbar triamcinolone acetonide injection for macular oedema related to branch retinal vein occlusion.
Kawaji T; Takano A; Inomata Y; Sagara N; Iwao K; Inatani M; Fukushima M; Tanihara H
Br J Ophthalmol; 2008 Jan; 92(1):81-3. PubMed ID: 17965103
[TBL] [Abstract][Full Text] [Related]
37. Detecting vitreomacular adhesions in eyes with asteroid hyalosis with triamcinolone acetonide.
Yamaguchi T; Inoue M; Ishida S; Shinoda K
Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):305-8. PubMed ID: 16411097
[TBL] [Abstract][Full Text] [Related]
38. Erosive Retinopathy and Retinal Detachment From Depot Intravitreal Triamcinolone Acetonide Injection at the End of Pars Plana Vitrectomy.
Sisk RA; Patel YP; Foster RE; Petersen MR
Ophthalmic Surg Lasers Imaging Retina; 2019 Oct; 50(10):613-619. PubMed ID: 31671193
[TBL] [Abstract][Full Text] [Related]
39. Vitreomacular adhesion and the defect in posterior vitreous cortex visualized by triamcinolone-assisted vitrectomy.
Doi N; Uemura A; Nakao K; Sakamoto T
Retina; 2005 Sep; 25(6):742-5. PubMed ID: 16141862
[TBL] [Abstract][Full Text] [Related]
40. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane.
Lai CC; Wang NK; Wu WC; Yeung L; Hwang YS; Chen KJ; Chen TL; Chuang LH
Cutan Ocul Toxicol; 2011 Dec; 30(4):292-7. PubMed ID: 21449851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
